Oncology
9th Annual World Cancer Series: Day 2
As Economist Impact’s World Cancer Series continues, Day Two firmly takes up focus on the patient voice, with a presentation by Eileen Page, chief executive of Innovation Advantage 2020 to
Patients
Sponsored
Voices to Trials: Engaging Patients in Clinical Trial Design
To improve trial recruitment, engagement, and retention, and to increase the likelihood that trials reflect what matters most to patients, regulatory authorities increasingly point to metho
Oncology
An oncology workforce fit for the future
To continue delivering high-quality and patient-centred care, the future oncology workforce of the NHS needs to be agile, expansive, and diverse.
Sales & Marketing
Sponsored
Before you start the strategic planning cycle: 5 essential t...
It’s about that time of year when many global teams turn their attention towards annual strategic planning.
Sales & Marketing
Sponsored
Coaching Never Sleeps
Coaching has developed into one of the most powerful tools in a fast-changing pharmaceutical sector.
Sales & Marketing
Partner Content
Amar Urhekar joins FH as Chief Operating Officer
WASHINGTON, D.C., Sept.
R&D
Partner Content
2nd Innate Killer Europe Summit
The 2nd Innate Killer Europe Summit will gather 80+ key European Gamma Delta T, NK, iNKT, neutrophil, and macrophage developers in October to chase the holy grail of efficacious, off-the-sh
Category :
Views & Analysis
/
